Article Versions Notes

Kim H-J, Kwak HW, Kang KW, Bang Y-J, Lee Y-S, Park H-J, Kim J-Y, Park H-J, Hwang K-A, Lee S-M, et al. MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice. Pharmaceutics. 2020; 12(5):441. https://doi.org/10.3390/pharmaceutics12050441

Kim, Hye-Jung, Hye Won Kwak, Kyung Won Kang, Yoo-Jin Bang, Yu-Sun Lee, Hyeong-Jun Park, Jae-Yong Kim, Hyo-Jung Park, Kyung-Ah Hwang, Sang-Myeong Lee, and et al. 2020. "MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice" Pharmaceutics 12, no. 5: 441. https://doi.org/10.3390/pharmaceutics12050441

Kim, H.-J., Kwak, H. W., Kang, K. W., Bang, Y.-J., Lee, Y.-S., Park, H.-J., Kim, J.-Y., Park, H.-J., Hwang, K.-A., Lee, S.-M., & Nam, J.-H. (2020). MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice. Pharmaceutics, 12(5), 441. https://doi.org/10.3390/pharmaceutics12050441